Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 613 of 6351
-
Timing is everything: new trial aims to reduce transplant complications by adjusting when stem cells are given
Disease control Recruiting nowTo observe the effect of stem cell infusion on the development of acute graft- versus-host disease (aGVHD) in patients with malignant hematologic diseases after single-unit unrelated cord blood transplantation (sUCBT).
Phase 3 • Sponsor: Anhui Provincial Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Can early plasma exchange save sight and mobility?
Disease control Recruiting nowThe purpose of this research is to evaluate if early vs rescue Therapeutic Plasma Exchange (PLEX) treatment algorithm leads to better visual outcomes in severe Optic Neuritis and leads to better neurological disability outcomes in severe Transverse Myelitis.
Phase 3 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Could a drug combo ease Alzheimer's agitation? large trial underway
Symptom relief Recruiting nowThe purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC in adult participants with agitation related to Alzheimer's Disease.
Phase 3 • Sponsor: Bristol-Myers Squibb • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
Can peer mentors help stop HIV transmission from mother to child?
Disease control Recruiting nowMentor Mothers (MMs) are peer supporters who help pregnant and postpartum women living with HIV (WLHIV) as they receive prevention of mother-to-child transmission of HIV (PMTCT) services in resource-limited settings like Kenya. Differentiated service delivery (DSD) is a care mode…
Sponsor: Indiana University • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Immunotherapy plus radiation aims to stop liver cancer recurrence
Disease control Recruiting nowThis study is an open-label, randomized controlled, multicenter, phase III clinical trial
Phase 3 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New device could keep donor hearts alive longer for transplant
Disease control Recruiting nowThe purpose of this study is to evaluate if Non-Ischemic Heart Preservation (NIHP) of extended criteria donor hearts using the XVIVO Heart Preservation System (XHPS) is a safe and effective way to preserve and transport hearts for transplantation.
Sponsor: XVIVO Perfusion • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Nanovaccine trains immune cells to hunt lung cancer
Disease control OngoingTumor-reactive T cells are generated based on the tumor full antigen nanovaccine and the tumor-reactive T cells are reinjected for autologous therapy to provide the optimal treatment plan for clinical patients.
Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Could a triple therapy stop strokes from coming back?
Disease control Recruiting nowCurrently, aspirin plus clopidogrel is considered as a standard acute treatment of ischemic stroke, based on results of CHANCE and POINT trial. However, still a considerable portion of patients showed early stroke recurrence, especially in those with stroke due to large artery at…
Phase 4 • Sponsor: Asan Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Engineered immune cells offer new hope for Hard-to-Treat leukemia
Disease control Recruiting nowRefractory/Relapsed (R/R) acute myeloid leukemia (AML) is associated with a dis-mal prognosis. In some subsets of AML such as AML driven by the t(8;21) translocation, leading to the RUNX1-RUNX1T1 (AML1-ETO) fusion transcript expression, CD19 B-cell antigen is aberrantly expresse…
Phase 1 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New drug combo may help save kidneys in High-Risk cancer patients
Disease control Recruiting nowThrough the neoadjuvant treatment with a combination of Pucotenlimab and Vorolanib, it enabled the successful and safe implementation of partial nephrectomy in patients with localized renal cancer, who had indications for nephron-sparing surgery but faced considerable difficulty …
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Ketamine booster for shock therapy? new trial aims to lift depression and protect memory
Symptom relief Recruiting nowThis is a randomized, double-blind, placebo-controlled phase 3 clinical trial evaluating the additive effect of intravenous ketamine in combination with electroconvulsive therapy (ECT) in patients with treatment-resistant major depressive disorder (MDD). The study aims to determi…
Phase 3 • Sponsor: Università Vita-Salute San Raffaele • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Mindfulness may be the antidote to teacher burnout
Symptom relief CompletedThis randomized controlled trial aims to evaluate the effectiveness of an eightweek Mindfulness-Based Stress Reduction (MBSR) program in reducing workplace stress among secondary school teachers from public and private schools in the Malakand Division, Khyber Pakhtunkhwa, Pakista…
Sponsor: Riphah International University • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
Kidney shield: a simple care bundle may prevent organ failure after severe injury
Disease control Recruiting nowAcute Kidney Injury (AKI) occurs in 24% of trauma patients, and is even more common in those with severe trauma. It is a major contributor to morbidity and mortality in trauma. Diagnosis of AKI is based on elevated serum creatinine and decreased urine output, two functional marke…
Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
New drug combo aims to boost immune attack on Hard-to-Treat prostate cancer
Disease control Recruiting nowA single-center phase Ib/II dose escalation and dose-expansion clinical trial of REGN5678 plus cemiplimab
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Can a Five-Day injection drain the fluid that weighs down heart failure patients?
Symptom relief CompletedTo Evaluate the Safety, Efficacy, and Pharmacokinetic/Pharmacodynamics Characteristics of JMKX003142 injection Administered Randomly,Double-blind, Placebo-controlled Study in Chinese Cardiacl Edema Patients.
Phase 2 • Sponsor: Jemincare • Aim: Symptom relief
Last updated Aug 08, 2026 00:03 UTC
-
MS patients may soon get a shot instead of an IV drip
Disease control OngoingThe purpose of this study is to assess the pharmacokinetics of ublituximab when administered subcutaneously (SC) compared to intravenous (IV) administration in participants with RMS.
Phase 3 • Sponsor: TG Therapeutics, Inc. • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Head-to-Head: which migraine pill works best?
Disease control Recruiting nowThis goal of this study is to compare three medications used for migraine preventive treatment. This study will compare atogepant, a newer migraine preventive medication, with two older preventive medications, topiramate and propranolol. It will be determined if one works better…
Phase 4 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Clot removal after heart attack: could it save lives?
Disease control Recruiting nowThe goal of this clinical trial is to determine whether manually removing a visible blood clot before percutaneous coronary intervention (PCI) improves outcomes in patients with ST-segment elevation myocardial infarction (STEMI). About 3500 patients who present within 24 hours of…
Sponsor: Shenghua Zhou • Aim: Disease control
Last updated Sep 10, 2026 04:00 UTC
-
Experimental drug aims to shield ICU patients from deadly infections
Disease control Recruiting nowThe goal of this clinical trial is to demonstrate the benefit of a standardized immunotherapy (Interferon gamma) on the incidence of secondary infections. . It will also learn about the safety of Interferon-gamma. The main questions it aims to answer are: Does Interferon-gamma: …
Phase 3 • Sponsor: University Hospital, Limoges • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Could a smarter pacemaker ease a common type of heart failure?
Disease control Recruiting nowELEVATE-HFpEF is a prospective, randomized, controlled, double-blinded, multi-center, global, interventional pivotal study evaluating the safety and efficacy of dual chamber personalized pacing compared to minimal or no pacing for the treatment of patients with heart failure with…
Sponsor: Medtronic Cardiac Rhythm and Heart Failure • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC